3089 Symptom analysis and quality of life (QoL) in patients treated with nivolumab (NIVO) as ≥2nd line therapy for advanced non-small cell lung cancer (aNSCLC)
Year: 2015
Type: article
Source: European Journal of Cancer
Authors: L. Schwartzberg, J. Chandler, C. Reynold, E.B. Garon, E.J. Stepanski, G.P. Keogh, K. Blankstein, J. Schneider, B. Korytowski, R. Sen, C. Coon, J. McDonald, X. Li, M. McCleod
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2511293644